Insilico Medicine closes $37mm Series B round

15:40 EDT 10 Oct 2019 | Elsevier Business Intelligence

Insilico Medicine Inc. raised $37mm through its Series B round led by Qiming Ventures and including Eight Roads, F-Prime Capi...

Original Article: Insilico Medicine closes $37mm Series B round


More From BioPortfolio on "Insilico Medicine closes $37mm Series B round"

Quick Search

Relevant Topics

Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...